Financial Ratios

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE264.80-0.55 (-0.21 %)
PREV CLOSE ( ) 265.35
OPEN PRICE ( ) 267.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35287
TODAY'S LOW / HIGH ( )262.75 271.75
52 WK LOW / HIGH ( )258.6 328.6
NSE265.05-1.1 (-0.41 %)
PREV CLOSE( ) 266.15
OPEN PRICE ( ) 269.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 265.05 (177)
VOLUME 260008
TODAY'S LOW / HIGH( ) 262.40 272.10
52 WK LOW / HIGH ( )250.1 329
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)6.3613.0210.806.858.36
   CEPS(Rs)15.2020.7817.7113.5415.89
   DPS(Rs)1.201.602.001.201.20
   Book NAV/Share(Rs)91.9386.6275.7066.2261.33
   Tax Rate(%)25.6126.5635.5033.2930.86
Margin Ratios
   Core EBITDA Margin(%)12.7117.5318.7718.1218.75
   EBIT Margin(%)7.5912.8614.1011.8813.05
   Pre Tax Margin(%)5.2111.2512.008.409.38
   PAT Margin (%)3.878.267.745.606.48
   Cash Profit Margin (%)9.2613.1912.6911.0712.33
Performance Ratios
   ROA(%)3.277.396.844.626.11
   ROE(%)7.1216.0415.2210.7414.46
   ROCE(%)8.4715.2116.1512.4415.25
   Asset Turnover(x)0.840.890.880.820.94
   Sales/Fixed Asset(x)1.371.541.571.491.82
   Working Capital/Sales(x)7.299.967.768.456.99
Efficiency Ratios
   Fixed Capital/Sales(x)0.730.650.640.670.55
   Receivable days79.3486.7387.6283.5673.14
   Inventory Days58.2555.9661.4481.9376.61
   Payable days92.7087.6786.5584.9069.37
Valuation Parameters
   PER(x)44.3530.9213.2910.2220.93
   PCE(x)18.5519.378.105.1711.01
   Price/Book(x)3.074.651.901.062.85
   Yield(%)0.430.401.391.710.69
   EV/Net Sales(x)2.062.881.360.961.75
   EV/Core EBITDA(x)15.8716.177.145.229.28
   EV/EBIT(x)27.1422.379.658.0713.43
   EV/CE(x)2.213.211.520.991.97
   M Cap / Sales1.722.551.030.571.36
Growth Ratio
   Net Sales Growth(%)4.1312.9214.14-5.1822.65
   Core EBITDA Growth(%)-24.025.3618.42-7.8322.01
   EBIT Growth(%)-38.562.9535.55-13.7429.20
   PAT Growth(%)-51.1720.5557.68-18.0933.47
   EPS Growth(%)-51.1720.5657.68-18.09-11.02
Financial Stability Ratios
   Total Debt/Equity(x)0.660.630.650.790.87
   Current Ratio(x)1.401.241.321.271.35
   Quick Ratio(x)0.940.840.940.790.79
   Interest Cover(x)3.198.006.703.413.55
   Total Debt/Mcap(x)0.220.140.340.750.31

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.